Australia TGA ARTG recordNeedle, injector, medication/vaccine
Australia TGA ARTG Registered Device · Roche Diabetes Care Australia Pty Ltd · HTL-Strefa S A · Class IIa · Started October 24, 2022
Good Name: Roche Diabetes Care Australia Pty Ltd - Needle, injector, medication/vaccine
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- October 24, 2022
- Effective Date
- October 24, 2022
- Name
- HTL-Strefa S A
- Country
- Poland
- Address
- ul Adamowek 7, Ozorkow, 95-035
Pen needles that are intended to be used with pen injector devices for the subcutaneous injection of drugs
Access comprehensive regulatory information for Needle, injector, medication/vaccine in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by HTL-Strefa S A in Poland. The device registration started on October 24, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.